The United States organ transplant system is designed to prioritize patients based on medical urgency and the likelihood of a successful outcome. However, data indicates that these systems have historically struggled to achieve equitable access across different demographics. A 2020 study highlighted a significant disparity, finding that women were 8.6 percent more likely to die while on the waiting list for a liver transplant compared to their male counterparts. Furthermore, the study noted that women were 14.4 percent less likely to receive a transplant from a deceased donor.

These findings prompted discussions regarding the fairness of the current allocation framework. While the system is intended to be neutral, critics argue that the metrics used to assess patient health may inadvertently disadvantage certain groups. The core of the debate centers on whether the current scoring systems—which determine who is 'sickest'—are calibrated accurately to account for physiological differences between men and women. While the system has undergone various policy adjustments to address these gaps, researchers and medical professionals continue to analyze whether these changes have successfully narrowed the mortality and transplant rate differences between genders. The ongoing challenge remains balancing the need for a standardized, objective medical criteria with the reality that biological and systemic factors can lead to unequal outcomes for patients in need of life-saving interventions.